INDOCO REMEDIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320.3 INR | -0.47% |
|
-2.54% | -18.95% |
| May. 16 | Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division | MT |
| May. 16 | Transcript : Indoco Remedies Limited, Q4 2024 Earnings Call, May 16, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 355M | - | - | ||||
| 694B | ||||||
| 593B | ||||||
| 371B | ||||||
| 331B | ||||||
| 290B |
